Literature DB >> 18046554

Patient demographics and disease variables correlate with distinct cytokine patterns in mitogen-stimulated peripheral blood mononuclear cells from rheumatoid arthritis patients.

Sukhbir Singh Uppal1, Raj Raghupathy, Sawsan J Hayat, Rafiqul Islam Chowdhury, Mini Abraham, Parvez Rawoot.   

Abstract

There is paucity of literature on the association of peripheral blood cytokine patterns with patient demographics and disease variables in rheumatoid arthritis (RA). We test the hypothesis that there may be differences in peripheral blood levels of inflammatory cytokines in RA subjects according to various disease variables. In this case, we could identify peripheral blood cytokine markers that correlate with different disease variables. Forty-two seropositive RA patients were characterized according to the age at onset, gender, disease duration, severity, activity and ACR functional class. The production levels in mitogen-stimulated PBMCs of five pro-inflammatory cytokines (IFNgamma, TNFalpha, TNFbeta, IL-8, IL-18) and three anti-inflammatory cytokines (IL-4, IL-10, IL-13) were evaluated in these patients and in healthy controls. Several new findings emerge: (1) higher levels of IL-4 correlate with female gender, milder disease, non-erosive disease, and earlier age at onset; (2) higher levels of IL-10 correlate with the requirement of < or =2 DMARDs; (3) higher levels of IL-18 correlate with non-erosive disease and younger age at onset; (4) higher TNFbeta levels correlate with older present age of patients; and (5) higher IL-8 levels correlate with established/late disease. There are several interesting differences in cytokine patterns with respect to age at onset, current age, disease severity, and the number of DMARDs the patients require.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18046554     DOI: 10.1007/s00296-007-0495-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  43 in total

1.  Guidelines for the management of rheumatoid arthritis: 2002 Update.

Authors: 
Journal:  Arthritis Rheum       Date:  2002-02

Review 2.  Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin-1 receptor antagonist.

Authors:  W P Arend
Journal:  Semin Arthritis Rheum       Date:  2001-04       Impact factor: 5.532

3.  Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.

Authors:  C M Verhoef; J A van Roon; M E Vianen; J W Bijlsma; F P Lafeber
Journal:  J Rheumatol       Date:  2001-09       Impact factor: 4.666

4.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

Review 5.  Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

Authors:  T G Wegmann; H Lin; L Guilbert; T R Mosmann
Journal:  Immunol Today       Date:  1993-07

Review 6.  Cytokine blockade in rheumatoid arthritis.

Authors:  M Feldmann; R N Maini; J Bondeson; P Taylor; B M Foxwell; F M Brennan
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

Review 7.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1990-03

8.  [Peripheral mononuclear cells and cytokine circulating levels during adalimumab therapy in patients with rheumatoid arthritis].

Authors:  Maurizio Benucci; Francesca Li Gobbi; Fiammetta Fossi; Emanuela Cammelli; Mariangela Manfredi
Journal:  Recenti Prog Med       Date:  2005-09

9.  Quantitative intracellular cytokine measurement: age-related changes in proinflammatory cytokine production.

Authors:  L O'Mahony; J Holland; J Jackson; C Feighery; T P Hennessy; K Mealy
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

10.  Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis.

Authors:  A H Gerards; S de Lathouder; E R de Groot; B A C Dijkmans; L A Aarden
Journal:  Rheumatology (Oxford)       Date:  2003-05-30       Impact factor: 7.580

View more
  1 in total

1.  Patterns of circulatory and peripheral blood mononuclear cytokines in rheumatoid arthritis.

Authors:  Fawaz Y Azizieh; Khaled Al Jarallah; Diaa Shehab; Renu Gupta; Kamaludin Dingle; Raj Raghupathy
Journal:  Rheumatol Int       Date:  2017-07-19       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.